CERTANA Trademark

Trademark Overview

On Monday, February 29, 2016, a trademark application was filed for CERTANA with the United States Patent and Trademark Office. The USPTO has given the CERTANA trademark a serial number of 86923801. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 14, 2025. This trademark is owned by Intarcia Therapeutics, Inc.. The CERTANA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Drug delivery systems; medical apparatus for the administration of pharmaceuticals; medical apparatus for treatment of diabetes, obesity and metabolic diseases/disorders

Pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases/disorders; an implantable subdermal drug delivery device filled with a pharmaceutical preparation for the treatment of diabetes, obesity and metabolic diseases/disorders
certana

General Information

Serial Number86923801
Word MarkCERTANA
Filing DateMonday, February 29, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 14, 2025
Registration Number5740101
Registration DateTuesday, April 30, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2016

Trademark Statements

Goods and ServicesDrug delivery systems; medical apparatus for the administration of pharmaceuticals; medical apparatus for treatment of diabetes, obesity and metabolic diseases/disorders
Goods and ServicesPharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases/disorders; an implantable subdermal drug delivery device filled with a pharmaceutical preparation for the treatment of diabetes, obesity and metabolic diseases/disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 14, 2025
Primary Code005
First Use Anywhere DateThursday, March 14, 2019
First Use In Commerce DateThursday, March 14, 2019
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 14, 2025
Primary Code010
First Use Anywhere DateThursday, March 14, 2019
First Use In Commerce DateThursday, March 14, 2019

Trademark Owner History

Party NameIntarcia Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameIntarcia Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameIntarcia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Thursday, March 3, 2016NEW APPLICATION ENTERED
Thursday, March 3, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 13, 2016ASSIGNED TO EXAMINER
Monday, June 13, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 29, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 19, 2016PUBLISHED FOR OPPOSITION
Tuesday, July 19, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 31, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, January 31, 2017SOU EXTENSION 1 FILED
Tuesday, January 31, 2017SOU EXTENSION 1 GRANTED
Thursday, February 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 2, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 2, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 16, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, August 16, 2017SOU EXTENSION 2 FILED
Wednesday, August 16, 2017SOU EXTENSION 2 GRANTED
Friday, August 18, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 28, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, February 28, 2018SOU EXTENSION 3 FILED
Wednesday, February 28, 2018SOU EXTENSION 3 GRANTED
Friday, March 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 18, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, July 18, 2018SOU EXTENSION 4 FILED
Wednesday, July 18, 2018SOU EXTENSION 4 GRANTED
Friday, July 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 5, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 5, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 5, 2019SOU TEAS EXTENSION RECEIVED
Monday, March 11, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 5, 2019SOU EXTENSION 5 FILED
Monday, March 11, 2019SOU EXTENSION 5 GRANTED
Tuesday, March 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 15, 2019TEAS STATEMENT OF USE RECEIVED
Friday, March 15, 2019USE AMENDMENT FILED
Monday, March 18, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 28, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 29, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 30, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, April 30, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 14, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

certana diabetes metabolic diseases disorders treatment obesity medical pharmaceutical drug delivery